Literature DB >> 25584678

An oncogenic enhancer enemy (N-Me) in T-ALL.

Daniel Herranz1, Adolfo A Ferrando.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25584678      PMCID： PMC4615101          DOI： 10.4161/15384101.2014.989129

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  8 in total

1.  Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice.

Authors:  Apostolos Klinakis; Matthias Szabolcs; Katerina Politi; Hippokratis Kiaris; Spyros Artavanis-Tsakonas; Argiris Efstratiadis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

2.  NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth.

Authors:  Teresa Palomero; Wei Keat Lim; Duncan T Odom; Maria Luisa Sulis; Pedro J Real; Adam Margolin; Kelly C Barnes; Jennifer O'Neil; Donna Neuberg; Andrew P Weng; Jon C Aster; Francois Sigaux; Jean Soulier; A Thomas Look; Richard A Young; Andrea Califano; Adolfo A Ferrando
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

3.  c-Myc mediates pre-TCR-induced proliferation but not developmental progression.

Authors:  Marei Dose; Irum Khan; Zhuyan Guo; Damian Kovalovsky; Andreas Krueger; Harald von Boehmer; Khashayarsha Khazaie; Fotini Gounari
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

4.  Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma.

Authors:  Thaddeus D Allen; Elena M Rodriguez; Kirk D Jones; J Michael Bishop
Journal:  Cancer Res       Date:  2011-07-29       Impact factor: 12.701

Review 5.  Recent advances on NOTCH signaling in T-ALL.

Authors:  Gannie Tzoneva; Adolfo A Ferrando
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

6.  Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors.

Authors:  Inderpreet Kaur Sur; Outi Hallikas; Anna Vähärautio; Jian Yan; Mikko Turunen; Martin Enge; Minna Taipale; Auli Karhu; Lauri A Aaltonen; Jussi Taipale
Journal:  Science       Date:  2012-11-01       Impact factor: 47.728

7.  Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.

Authors:  Junwei Shi; Warren A Whyte; Cinthya J Zepeda-Mendoza; Joseph P Milazzo; Chen Shen; Jae-Seok Roe; Jessica L Minder; Fatih Mercan; Eric Wang; Melanie A Eckersley-Maslin; Amy E Campbell; Shinpei Kawaoka; Sarah Shareef; Zhu Zhu; Jude Kendall; Matthias Muhar; Christian Haslinger; Ming Yu; Robert G Roeder; Michael H Wigler; Gerd A Blobel; Johannes Zuber; David L Spector; Richard A Young; Christopher R Vakoc
Journal:  Genes Dev       Date:  2013-11-27       Impact factor: 11.361

8.  A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.

Authors:  Daniel Herranz; Alberto Ambesi-Impiombato; Teresa Palomero; Stephanie A Schnell; Laura Belver; Agnieszka A Wendorff; Luyao Xu; Mireia Castillo-Martin; David Llobet-Navás; Carlos Cordon-Cardo; Emmanuelle Clappier; Jean Soulier; Adolfo A Ferrando
Journal:  Nat Med       Date:  2014-09-07       Impact factor: 53.440
  8 in total
  1 in total

1.  Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia.

Authors:  Mengping Xi; Shanshan Guo; Caicike Bayin; Sophie Rousseaux; Saadi Khochbin; Jian-Qing Mi; Jin Wang; Lijun Peng; Florent Chuffart; Ekaterina Bourova-Flin
Journal:  Front Med       Date:  2021-10-20       Impact factor: 9.927
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.